Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Biogen Plans European Manufacturing Plant
Biogen Inc. is planning to build its first European manufacturing facility on 60 acres purchased in the Municipality of Hillerod, Denmark. With an option to buy an additional 36 acres, the Cambridge, Ma.-based firm has allotted $350 million to develop the project.
KLA-Tencor Slows Livermore Development
KLA-Tencor has put occupation of its new Livermore campus on hold until the end of the year. The San Jose-based semiconductor firm purchased 43 acres in the Shea Business Park in May 2000 for a 720,000-sf, six-building campus. Construction on the two buildings to house manufacturing and customer service will continue; totaling 120,000-sf, the facilities are nearing completion.
Hybrigen Doubles Dallas Facilities
Hybrigen Inc., a Dallas drug-targeting company, doubled its biotechnology facility's space to 8,000-sf in May. Hybrigen is one of several biotech-related companies located in Dallas' Stemmons Corridor area.
Bayer Diagnostic Negotiates East Bay Expansion
Bayer Diagnostic, a separate entity within the German pharmaceutical firm, is negotiating occupation of 70,000 sf in a yet-to-be built biotech laboratory and office building in Berkeley. The two-story facility, slated for completion in mid-2002, will be developed by Wareham Development of San Rafael, Ca. HKA Architects has been selected for the exterior drawings, with Darrell de Tienne providing conceptual design.
Tularik Builds Dallas Lab
Tularik Texas, a subsidiary of South San Francisco-based biotech firm Tularik, is leasing and building out a laboratory space in Dallas. The 2,300-sf facility will focus on anti-fungal and anti-bacterial drug development and is due to open in September.